Genmab A/S Interest Expense On Other Financial Liabilities
Genmab A/S (GMAB) reported Interest Expense On Other Financial Liabilities of $34.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-17.
Financial Statements › Expense Statement › Interest Expense
ifrs-full:InterestExpenseOnOtherFinancialLiabilities · last filed 2026-02-17
| Period end | Interest Expense On Other Financial Liabilities 12 month |
|---|---|
| 2025-12-31 | $34.00M 20-F · filed 2026-02-17 |
| 2024-12-31 | $18.00M 20-F · filed 2026-02-17 |
| 2023-12-31 | $10.00M 20-F · filed 2026-02-17 |